Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients
Introduction: Breast cancer is the most common malignancy in women, and it is the second leading cause of malignancy-related mortality in women after lung cancer. Locally advanced breast cancer is a clinically heterogeneous group with a broad spectrum. Neoadjuvant chemotherapy (NAC) is the standard...
Saved in:
Main Authors: | Çiğdem Yıldırım, Fatih Teker, İlker Nihat Ökten, İlkay Gültürk, Aydın Aytekin, Alper Aytekin, Latif Yılmaz, Çiğdem Usul Afşar |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2024-11-01
|
Series: | İstanbul Medical Journal |
Subjects: | |
Online Access: | https://istanbulmedicaljournal.org/articles/relationship-of-neoadjuvant-chemotherapy-efficacy-with-histopathologic-molecular-subtypes-in-breast-cancer-patients/doi/imj.galenos.2024.96266 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Locoregional recurrence after neoadjuvant versus adjuvant chemotherapy based on tumor subtypes in patients with early-stage breast cancer: A multi-institutional retrospective cohort study
by: Jong-Ho Cheun, et al.
Published: (2024-12-01) -
A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer
by: Freshte Foroughi, et al.
Published: (2024-12-01) -
Does Apoptotic Index Predict the Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma?
by: Gokce ASKAN, et al.
Published: (2023-03-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)